Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "disease-diagnosis"

13 News Found

Quest Diagnostics’ study confirms accuracy of blood tests for Alzheimer’s disease diagnosis
R&D | October 30, 2025

Quest Diagnostics’ study confirms accuracy of blood tests for Alzheimer’s disease diagnosis

Quest Diagnostics’ blood-based test panels demonstrate confirmatory accuracy, potentially reducing the need for PET imaging


MedGenome to expand integrated diagnostics access across Mumbai suburbs
Healthcare | May 19, 2026

MedGenome to expand integrated diagnostics access across Mumbai suburbs

Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets


Healthcare policymakers lay thrust on genetic screening and indigenous therapies for rare diseases
Public Health | May 05, 2026

Healthcare policymakers lay thrust on genetic screening and indigenous therapies for rare diseases

Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access


India tackles rare diseases head-on at landmark summit in New Delhi
News | March 12, 2026

India tackles rare diseases head-on at landmark summit in New Delhi

Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration


Quest Diagnostics reports strong third quarter 2025 results and raises full-year guidance
News | October 25, 2025

Quest Diagnostics reports strong third quarter 2025 results and raises full-year guidance

Revenues up 13.1% year-over-year; Continued momentum driven by organic growth, strategic partnerships, and acquisitions


FDA expands Repatha indication to adults at risk of major cardiovascular events from uncontrolled LDL-C
News | August 28, 2025

FDA expands Repatha indication to adults at risk of major cardiovascular events from uncontrolled LDL-C

The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia


NHA and IIT Kanpur sign MoU for development of digital public goods for AI in healthcare
Digitisation | September 11, 2024

NHA and IIT Kanpur sign MoU for development of digital public goods for AI in healthcare

The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform


PredOmix, Core Diagnostics partner to launch OncoVeryx-F
Clinical Trials | July 18, 2023

PredOmix, Core Diagnostics partner to launch OncoVeryx-F

OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection


SMi discloses £6 million seed funding round, bolsters team with new C-suite hire
News | June 15, 2023

SMi discloses £6 million seed funding round, bolsters team with new C-suite hire

Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics


Roche introduces navify sample tracking for labs to track patient test samples
News | May 23, 2023

Roche introduces navify sample tracking for labs to track patient test samples

navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.